CLYM Climb Bio Inc: Multiplikator Forward P/S
Climb Bio Inc develops advanced therapies for complex inflammatory pathologies. P/S expectations for the company reflect market optimism, where the metric determines the status of the valuation parameter. Management strictly controls resources for antibody development. Business success is based on advancing budigalimab into late-stage trials and securing major partners.
Ringkesan rincian data analitis Climb Bio, Inc (CLYM)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- data tingkat utang lan likuiditas finansial:
Utang marang Ekuitas Climb Bio Inc|CLYM - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Climb Bio Inc|CLYM - Utang perusahaan|Utang marang nilai buku Climb Bio, Inc|CLYM - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Climb Bio|Rasio cepet climbbio.com
- data bathi bisnis lan rasio investasi:
CLYM - Asil keuangan resik|Bathi sing dikarepake Climb Bio Inc|CLYM - Kapitalisasi marang bathi|Prakiraan rega marang bathi Climb Bio, Inc.|CLYM - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Climb Bio, Inc|CLYM - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Climb Bio|CLYM - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan climbbio.com|CLYM - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Climb Bio Inc
- indikator pendapatan dodolan lan penghasilan bisnis:
Ringkesan analitik perusahaan:Climb Bio (CLYM)
Climb Bio Inc (CLYM) ethical ESG standards in drug development mitigate regulatory risks, directly impacting the stability of future cash flows. The forward P/S ratio compares current market capitalization with expected revenue, allowing investors to assess the rate of multiple compression and the risk of a "value trap" in the event of declining demand, as illustrated on this chart.
Pesaing wigati
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Abivax Corp - Multiplikator Forward P/S|ADMA Corp (ADMA) - Multiplikator forward rega marang pendapatan|Protagonist Therapeutics (PTGX) - Rasio rega marang prakiraan pendapatan|IMVT (immunovant.com) - Rasio rega marang prakiraan pendapatan|KNSA (Kiniksa) - Multiplikator Forward P/S|Grifols SA (GRFS) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Adaptive Biotechnologies Corp (ADPT)|Multiplikator forward rega marang pendapatan Celldex Corp CLDX|Multiplikator Forward P/S AUPH (Aurinia Pharmaceuticals)|biocryst.com - Rasio rega marang prakiraan pendapatan|VERA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan DNTH (Dianthus Therapeutics Inc)|PHVS: Multiplikator Forward P/S|ABCL (AbCellera Corp) - Rasio rega marang prakiraan pendapatan|TRML (Tourmaline Bio, Inc.) - Multiplikator Forward P/S|precigen.com (PGEN) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Pharming Group (PHAR)|NKTR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Upstream Bio Corp - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan ZBIO|Immunome, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake gossamerbio.com GOSS|KalVista Pharmaceuticals, Inc. (KALV) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan SEPN|PVLA (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Savara Pharma (SVRA)|Multiplikator Forward P/S RIGL|Multiplikator forward rega marang pendapatan anaptysbio.com ANAB|Rasio rega marang prakiraan pendapatan Astria Therapeutics, Inc. ATXS|enGene Holdings Inc - Rasio rega marang prakiraan pendapatan|RAPT: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aerovate Therapeutics Inc|Aclaris Therapeutics (ACRS) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan kyvernatx.com|Rasio rega marang prakiraan pendapatan Tiziana Life Sciences Ltd|Cabaletta Bio Inc. - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S VTYX|THTX (Theratechnologies, Inc) - Rega forward marang dodolan|Multiplikator Forward P/S AVTX (Avalo Therapeutics, Inc)|Multiplikator Forward P/S eledon.com ELDN|AGEN - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan ZURA (Zura Bio Ltd)|aTyr (ATYR) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Adagene Inc.|IMA (ImageneBio) - Multiplikator Forward P/S|Multiplikator Forward P/S Shattuck Therapeutics|Multiplikator forward rega marang pendapatan EQ (Equillium, Inc.)|CNTB (connectbiopharm.com) - Rega forward marang dodolan|Multiplikator Forward P/S IMUX (Immunic)|Rasio kapitalisasi marang dodolan sing dikarepake Atara Biotherapeutics, Inc. (ATRA)|IFRX - Rasio rega marang prakiraan pendapatan|x4pharma.com (XFOR) - Multiplikator forward rega marang pendapatan|adicetbio.com (ACET) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Celularity|Multiplikator forward rega marang pendapatan INMB|Multiplikator Forward P/S Barinthus Biotherapeutics Corp|Rasio rega marang prakiraan pendapatan Kezar Life Sciences (KZR)|sabbiotherapeutics.com - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S AKTX (Akari Therapeutics Plc)|Enlivex Therapeutics Ltd (ENLV) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Q32 Bio Corp - Multiplikator Forward P/S|GeoVax Corp (GOVX) - Multiplikator forward rega marang pendapatan|Edesa Biotech, Inc. (EDSA) - Rasio rega marang prakiraan pendapatan|IBIO (ibioinc.com) - Rasio rega marang prakiraan pendapatan|CARM (Carisma Therapeutics Inc) - Multiplikator Forward P/S|XTL Biopharmaceuticals Ltd (XTLB) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Bolt Biotherapeutics (BOLT)|Multiplikator forward rega marang pendapatan hcwbiologics.com HCWB|Multiplikator Forward P/S APVO (Aptevo Therapeutics Inc.)|AIM ImmunoTech, Inc. - Rasio rega marang prakiraan pendapatan|ADTX: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan GRI (GRI Bio Inc)|XRTX: Multiplikator Forward P/S|HIND (Vyome Therapeutics) - Rasio rega marang prakiraan pendapatan|REVB (Revelation Biosciences) - Multiplikator Forward P/S|indaptusrx.com (INDP) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Scinai Immunotherapeutics Ltd. (SCNI)|CALI - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Affimed N.V. - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan ALLK|HOOKIPA - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IGM Biosciences, Inc. IGMS|iTeos Therapeutics, Inc. (ITOS) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan OCEA|TCBP (TC BioPharm (Holdings) PLC) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Third Harmonic Bio Inc (THRD)
